View in EDS

PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significance.

Saved in:
Bibliographic Details
Title: PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significance.
Authors: García LF; Department of Medical Oncology, Hospital Universitario La Paz, Research Institute, IdiPAZ, Madrid, Spain., Conde E; Department of Pathology, Hospital Universitario 12 de OctubreUniversidad Complutense de Madrid, Research Institute Hospital12 de Octubre (imas12), CIBERONC, Av. de Córdoba S/N, 28041, Madrid, Spain., Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre. Research Institute Hospital, 12 de Octubre (imas12), Madrid, Spain., Alonso M; Department of Pathology, Hospital Universitario 12 de Octubre. Research Institute Hospital, 12 de Octubre (imas12), Madrid, Spain., Curto D; Department of Pathology, Hospital Universitario 12 de Octubre. Research Institute Hospital, 12 de Octubre (imas12), Madrid, Spain., Dómine M; Department of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Rojo F; Department of Pathology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Freire J; Department of Pathology, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain., Gómez-Román J; Department of Pathology, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain., Calles A; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Cebollero M; Department of Pathology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., González-Larriba JL; Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain., Saiz M; Department of Pathology, Hospital Universitario Clínico San Carlos, Madrid, Spain., Esteban I; Department of Pathology, Hospital Universitario La Paz, Research Institute, IdiPAZ, Madrid, Spain., Gutiérrez L; Department of Medical Oncology, Hospital Universitario La Paz, Research Institute, IdiPAZ, Madrid, Spain., Lopez-Rios F; Department of Pathology, Hospital Universitario 12 de OctubreUniversidad Complutense de Madrid, Research Institute Hospital12 de Octubre (imas12), CIBERONC, Av. de Córdoba S/N, 28041, Madrid, Spain. fernandolopezriosmoreno@gmail.com., de Castro J; Department of Medical Oncology, Hospital Universitario La Paz, Research Institute, IdiPAZ, Madrid, Spain.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Feb; Vol. 28 (2), pp. 484-493. Date of Electronic Publication: 2025 Aug 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/s12094-025-04013-w